The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $2.46 in the prior trading day, BioCardia Inc. (NASDAQ: BCDA) closed at $2.20, down -10.57%. In other words, the price has decreased by -$10.57 from its previous closing price. On the day, 0.16 million shares were traded. BCDA stock price reached its highest trading level at $2.5691 during the session, while it also had its lowest trading level at $1.96.
Ratios:
Our goal is to gain a better understanding of BCDA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.39 and its Current Ratio is at 0.39.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’24 when Altman Peter bought 300 shares for $3.05 per share. The transaction valued at 915 led to the insider holds 39,745 shares of the business.
Altman Peter bought 200 shares of BCDA for $598 on Jun 28 ’24. The President and CEO now owns 39,445 shares after completing the transaction at $2.99 per share. On Jun 21 ’24, another insider, Altman Peter, who serves as the President and CEO of the company, bought 500 shares for $3.29 each. As a result, the insider paid 1,645 and bolstered with 39,245 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCDA now has a Market Capitalization of 5224736 and an Enterprise Value of 4389527. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.85. Its current Enterprise Value per Revenue stands at 10.256 whereas that against EBITDA is -0.515.
Stock Price History:
Over the past 52 weeks, BCDA has reached a high of $23.25, while it has fallen to a 52-week low of $2.42. The 50-Day Moving Average of the stock is -25.96%, while the 200-Day Moving Average is calculated to be -63.80%.
Shares Statistics:
The stock has traded on average 170.03K shares per day over the past 3-months and 265340 shares per day over the last 10 days, according to various share statistics. A total of 1.58M shares are outstanding, with a floating share count of 1.50M. Insiders hold about 29.21% of the company’s shares, while institutions hold 4.08% stake in the company. Shares short for BCDA as of 1723680000 were 64851 with a Short Ratio of 0.38, compared to 1721001600 on 29390. Therefore, it implies a Short% of Shares Outstanding of 64851 and a Short% of Float of 3.46.
